Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 121

    1.

    Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): Multiple-event analysis of risk factors for reoperations. SPR Study report no. 4.

    Heussen N, Hilgers RD, Heimann H, Collins L, Grisanti S; for the SPR study group*.

    Acta Ophthalmol. 2009 Nov 11. [Epub ahead of print]PMID: 19909291 [PubMed - as supplied by publisher]Related articles

    2.

    Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience.

    Sivaprasad S, Hykin P, Saeed A, Beatty S, Grisanti S, Staurenghi G, Olea JL, Campos A, Barbosa A, Rito L, Silva R, Faria R, Eldem B, Kadayıfçılar S, Kolar P, Feucht N, Maestroni L.

    Eye (Lond). 2009 Sep 25. [Epub ahead of print]PMID: 19786957 [PubMed - as supplied by publisher]Related articles

    3.

    Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.

    Suesskind D, Ulmer A, Schiebel U, Fierlbeck G, Spitzer B, Spitzer MS, Bartz-Schmidt KU, Grisanti S.

    Acta Ophthalmol. 2009 Sep 11. [Epub ahead of print]PMID: 19747222 [PubMed - as supplied by publisher]Related articles

    4.

    The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.

    Br J Ophthalmol. 2009 Oct;93(10):1396-400. Epub 2009 Jul 23.PMID: 19628500 [PubMed - indexed for MEDLINE]Related articles

    5.

    CCR3 is a target for age-related macular degeneration diagnosis and therapy.

    Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J.

    Nature. 2009 Jul 9;460(7252):225-30. Epub 2009 Jun 14.PMID: 19525930 [PubMed - indexed for MEDLINE]Related articles

    6.

    Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

    Ziemssen F, Grisanti S, Bartz-Schmidt KU, Spitzer MS.

    Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002. Review.PMID: 19476398 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery]

    Lüke J, Lüke M, Grisanti S.

    Ophthalmologe. 2009 May;106(5):407-12. Review. German. PMID: 19418055 [PubMed - indexed for MEDLINE]Related articles

    8.

    Current and future therapies for age-related macular degeneration.

    Beutel J, Rudolf M, Grisanti S.

    Expert Opin Emerg Drugs. 2009 Jun;14(2):341-62. Review.PMID: 19392638 [PubMed - indexed for MEDLINE]Related articles

    9.

    HER-2 OVEREXPRESSION/AMPLIFICATION IN BARRETT'S ESOPHAGUS PREDICTS EARLY TRANSITION FROM DYSPLASIA TO ADENOCARCINOMA: A CLINICO-PATHOLOGIC STUDY.

    Rossi E, Grisanti S, Villanacci V, Casa DD, Cengia P, Missale G, Minelli L, Buglione M, Cestari R, Bassotti G.

    J Cell Mol Med. 2008 Oct 6. [Epub ahead of print]PMID: 19292734 [PubMed - as supplied by publisher]Related articles

    10.

    Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.

    Tatar O, Adam A, Shinoda K, Kaiserling E, Boeyden V, Claes C, Eckardt C, Eckert T, Pertile G, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

    Arch Ophthalmol. 2009 Mar;127(3):275-81.PMID: 19273790 [PubMed - indexed for MEDLINE]Related articles

    11.

    Sodium hyaluronate gels as a drug-release system for corticosteroids: release kinetics and antiproliferative potential for glaucoma surgery.

    Spitzer MS, Yoeruek E, Kaczmarek RT, Sierra A, Aisenbrey S, Grisanti S, Bartz-Schmidt KU, Szurman P.

    Acta Ophthalmol. 2008 Dec;86(8):842-8.PMID: 19086928 [PubMed - indexed for MEDLINE]Related articles

    12.

    Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett's esophagus: a translational approach.

    Villanacci V, Rossi E, Grisanti S, Bassotti G, Ferrari VD, Missale G, Minelli L, Cengia P, Marini G, Cestari R.

    Minerva Gastroenterol Dietol. 2008 Dec;54(4):347-53.PMID: 19047975 [PubMed - indexed for MEDLINE]Related articles

    13.

    Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.

    Tatar O, Shinoda K, Kaiserling E, Claes C, Eckardt C, Eckert T, Pertile G, Boeyden V, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group, Grisanti S.

    Br J Ophthalmol. 2009 Feb;93(2):159-65. Epub 2008 Oct 6.PMID: 18838410 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model]

    Beutel J, Lüke M, Bartz-Schmidt KU, Grisanti S.

    Ophthalmologe. 2009 Oct;106(10):893-8. German. PMID: 18830601 [PubMed - in process]Related articles

    15.

    Analysis of the neuronal marker protein gene product 9.5 in internal limiting membranes after indocyanine-green assisted peeling.

    Peters S, Tatar O, Spitzer MS, Szurman P, Aisenbrey S, Lüke M, Adam A, Yoeruek E, Grisanti S.

    Retina. 2009 Feb;29(2):243-7.PMID: 18827736 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: A case report and review of literature.

    Grisanti S, Amoroso V, Buglione M, Rosati A, Gatta R, Pizzocaro C, Ferrari VD, Marini G.

    J Med Case Reports. 2008 Sep 30;2:320.PMID: 18826647 [PubMed - in process]Related articlesFree article

    17.

    Bevacizumab as adjuvant for neovascular glaucoma.

    Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer MS, Yoeruek E; the Bevacizumab Study Group, Grisanti S.

    Acta Ophthalmol. 2008 Sep 20. [Epub ahead of print]PMID: 18811641 [PubMed - as supplied by publisher]Related articles

    18.

    [Chances and risks of anti-VEGF therapy]

    Ziemssen F, Heiduschka P, Peters S, Grisanti S, Schraermeyer U.

    Klin Monbl Augenheilkd. 2008 Sep;225(9):770-8. Review. German. PMID: 18759208 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma.

    Valcamonico F, Ferrari V, Amoroso V, Rangoni G, Simoncini E, Marpicati P, Vassalli L, Grisanti S, Marini G.

    J Neurooncol. 2009 Jan;91(1):47-50. Epub 2008 Aug 19.PMID: 18712279 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.

    Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X; Tübingen Bevacizumab Study Group, Grisanti S.

    Ophthalmology. 2008 Oct;115(10):1750-5, 1755.e1. Epub 2008 Aug 16.PMID: 18708261 [PubMed - indexed for MEDLINE]Related articles

    21.

    Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.

    Ulmer A, Beutel J, Süsskind D, Hilgers RD, Ziemssen F, Lüke M, Röcken M, Rohrbach M, Fierlbeck G, Bartz-Schmidt KU, Grisanti S.

    Clin Cancer Res. 2008 Jul 15;14(14):4469-74.PMID: 18628461 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.

    Grisanti S, Tatar O.

    Prog Retin Eye Res. 2008 Jul;27(4):372-90. Epub 2008 Jul 14. Review.PMID: 18621565 [PubMed - indexed for MEDLINE]Related articles

    23.

    Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization.

    Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tübingen Bevacizumab Study Group, Adam A, Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, Scharioth GB, Grisanti S.

    Arch Ophthalmol. 2008 Jun;126(6):782-90.PMID: 18541840 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Safety parameters for indocyanine green in vitreoretinal surgery.

    Grisanti S, Altvater A, Peters S.

    Dev Ophthalmol. 2008;42:43-68. Review.PMID: 18535380 [PubMed - indexed for MEDLINE]Related articles

    25.

    The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P.

    Exp Eye Res. 2008 Jul;87(1):22-9. Epub 2008 Apr 23.PMID: 18514644 [PubMed - indexed for MEDLINE]Related articles

    26.

    Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.

    Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group, Ziemssen T.

    Int Ophthalmol. 2009 Aug;29(4):213-24. Epub 2008 Apr 17.PMID: 18418553 [PubMed - indexed for MEDLINE]Related articles

    27.

    Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.

    Yoeruek E, Spitzer MS, Tatar O, Biedermann T, Grisanti S, Lüke M, Bartz-Schmidt KU, Szurman P.

    Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1392-7.PMID: 18385055 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.

    Tatar O, Shinoda K, Kaiserling E, Pertile G, Eckardt C, Mohr A, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

    Arch Ophthalmol. 2008 Feb;126(2):193-9.PMID: 18268209 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Lüke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):817-22. Epub 2008 Jan 16.PMID: 18197412 [PubMed - indexed for MEDLINE]Related articles

    30.

    A new fixation aid for the radiotherapy of eye tumors.

    Buchgeister M, Grisanti S, Süsskind D, Bamberg M, Paulsen F.

    Med Phys. 2007 Dec;34(12):4649-53.PMID: 18196792 [PubMed - indexed for MEDLINE]Related articles

    31.

    A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.

    Reni M, Berardi R, Mambrini A, Pasetto L, Cereda S, Ferrari VD, Cascinu S, Cantore M, Mazza E, Grisanti S.

    Cancer Chemother Pharmacol. 2008 Sep;62(4):673-8. Epub 2008 Jan 3.PMID: 18172650 [PubMed - indexed for MEDLINE]Related articles

    32.

    Safety profile of a taurine containing irrigation solution (AcriProTect) in pars plana vitrectomy.

    Yoeruek E, Jägle H, Lüke M, Grisanti S, Warga M, Krott R, Spitzer MS, Tatar O, Bartz-Schmidt KU, Szurman P.

    Retina. 2007 Nov-Dec;27(9):1286-91.PMID: 18046239 [PubMed - indexed for MEDLINE]Related articles

    33.

    Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

    Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P; Tübingen Bevacizumab Study Group.

    Acta Ophthalmol. 2008 May;86(3):322-8. Epub 2007 Nov 8.PMID: 17995975 [PubMed - indexed for MEDLINE]Related articles

    34.

    Bevacizumab: off-label use in ophthalmology.

    Grisanti S, Ziemssen F.

    Indian J Ophthalmol. 2007 Nov-Dec;55(6):417-20. Review.PMID: 17951896 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Systematic evaluation of ICG and trypan blue related effects on ARPE-19 cells in vitro.

    Peters S, Altvater A, Bopp S, Vonthein R, Szurman P, Spitzer MS, Warga M, Lueke M, Bartz-Schmidt KU, Grisanti S.

    Exp Eye Res. 2007 Dec;85(6):880-9. Epub 2007 Sep 5.PMID: 17920588 [PubMed - indexed for MEDLINE]Related articles

    36.

    Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration.

    Tatar O, Adam A, Shinoda K, Yoeruek E, Szurman P, Bopp S, Eckardt C, Bartz-Schmidt KU, Grisanti S.

    Retina. 2007 Jul-Aug;27(6):713-23.PMID: 17621180 [PubMed - indexed for MEDLINE]Related articles

    37.

    Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria.

    Amoroso V, Pittiani F, Grisanti S, Valcamonico F, Simoncini E, Ferrari VD, Marini G.

    BMC Cancer. 2007 Jun 1;7:94.PMID: 17540044 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.

    Tatar O, Adam A, Shinoda K, Eckert T, Scharioth GB, Klein M, Yoeruek E, Bartz-Schmidt KU, Grisanti S.

    Br J Ophthalmol. 2007 Sep;91(9):1183-9. Epub 2007 May 2.PMID: 17475706 [PubMed - indexed for MEDLINE]Related articles

    39.

    Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo.

    Szurman P, Sierra A, Kaczmarek R, Jaissle GB, Wallenfels-Thilo B, Grisanti S, Lüke M, Bartz-Schmidt KU, Spitzer MS.

    Exp Eye Res. 2007 Jul;85(1):44-53. Epub 2007 Mar 19.PMID: 17475249 [PubMed - indexed for MEDLINE]Related articles

    40.

    Primary silicone oil tamponade in the management of severe intraocular foreign body injuries: an 8-year follow-up.

    Szurman P, Roters S, Grisanti S, Aisenbrey S, Rohrbach JM, Warga M, Gelisken F, Spitzer MS, Bartz-Schmidt KU.

    Retina. 2007 Mar;27(3):304-11.PMID: 17460585 [PubMed - indexed for MEDLINE]Related articles

    41.

    The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.

    Tura A, Grisanti S, Petermeier K, Henke-Fahle S.

    Invest Ophthalmol Vis Sci. 2007 May;48(5):2152-61.PMID: 17460274 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.

    Lüke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, Grisanti S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P; for the Tuebingen Bevacizumab Study Group.

    Br J Ophthalmol. 2007 Aug;91(8):1077-82. Epub 2007 Mar 23.PMID: 17383998 [PubMed - indexed for MEDLINE]Related articles

    43.

    Inner limiting membrane as membranous support in RPE sheet-transplantation.

    Beutel J, Greulich L, Lüke M, Ziemssen F, Szurman P, Bartz-Schmidt KU, Grisanti S.

    Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1469-73. Epub 2007 Mar 7.PMID: 17342501 [PubMed - indexed for MEDLINE]Related articles

    44.

    Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

    Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1085-95.PMID: 17219106 [PubMed - indexed for MEDLINE]Related articles

    45.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    46.

    Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

    Peters S, Julien S, Heiduschka P, Grisanti S, Ziemssen F, Adler M, Schraermeyer U, Bartz-Schmidt KU.

    Br J Ophthalmol. 2007 Jun;91(6):827-31. Epub 2006 Dec 19.PMID: 17179166 [PubMed - indexed for MEDLINE]Related articles

    47.

    Ultrastructural changes after artificial retinal detachment with modified retinal adhesion.

    Szurman P, Roters S, Grisanti S, Aisenbrey S, Schraermeyer U, Lüke M, Bartz-Schmidt KU, Thumann G.

    Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4983-9.PMID: 17065517 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    The international intravitreal bevacizumab safety survey.

    Ziemssen F, Grisanti S, Bartz-Schmidt KU.

    Br J Ophthalmol. 2006 Nov;90(11):1440-1. No abstract available. PMID: 17057183 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Influence of different purification techniques on triamcinolone yield and particle size spectrum.

    Szurman P, Kaczmarek R, Jaissle GB, Grisanti S, Lüke M, Spitzer MS, Heide PE, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):689-96. Epub 2006 Sep 28.PMID: 17006679 [PubMed - indexed for MEDLINE]Related articles

    50.

    Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

    Tatar O, Shinoda K, Adam A, Eckert T, Eckardt C, Lucke K, Deuter C, Bartz-Schmidt KU, Grisanti S.

    Br J Ophthalmol. 2007 Feb;91(2):166-73. Epub 2006 Sep 20.PMID: 16987895 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...